As CRISPR moves from lab success to real-world medicine, 2026 will test whether these revolutionary gene-editing therapies ...

Silence from Scripture on new technologies and the ethical questions they raise is no excuse for silence from the church.

GEN’s first virtual event of 2026—we present a group of outstanding researchers and thought-leaders to discuss the latest advances and challenges in delivering genetic therapies.

New York, United States, January 7th, 2026, FinanceWireGlobal investment management leader Aurum Capital has announced the ...

Understanding why cancer cells rely on specific genes is critical for designing effective targeted therapies. A new study ...

Clinical laboratory professionals are transforming healthcare for expectant mothers and their babies, according ...

H 2026 Catalyst Stack Anticipated to Validate Scalable, Off-the-Shelf CAR T in Oncology and Autoimmune DiseaseInterim Futility Analysis of MRD Clearance from the Pivotal Phase 2 ALPHA3 Trial with ...

Their award-winning projects in the prestigious competition cover topics in the sciences, engineering, social sciences and ...

Currently, a PhD position within the ACHILLES program is announced at Karolinska Institutet.As a PhD student in the European ...

Regeneron Pharmaceuticals (NASDAQ: REGN) underwent analysis by 21 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish.

Since 2019, three disease-specific therapies have been approved to treat patients with ATTR-CM. The first was Pfizer’s Vyndamax (tafamidis) in May 2019, which was approved for both wild type and ...

Dr. Dan Belsky joins WIRED to answer the internet's burning questions about longevity and epidemiology. Why do we grow old ...